Immunovant Inc (IMVT)
Healthcare
Biotechnology
38.50 $
-0.3%
vs. previous close
Closing price · As of: 3. Aug 2026
Immunovant Inc (IMVT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at -407 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| -128 | – | -29 | -53 | -83 | -106 | -188 | -214 | -376 | -407 | |
| 0.0 | – | 0.0 | 0.0 | 1.0 | 0.1 | 0.2 | 0.2 | 0.4 | 0.4 | |
| 1.8 | – | 1.3 | 7.0 | 19 | 34 | 32 | 41 | 49 | 56 | |
| 2.5 | – | 1.5 | 6.6 | 19 | 34 | 32 | – | – | – | |
| 1.4 | – | -0.5 | 4.8 | 4.6 | 15 | -11 | 2.6 | -12 | 42 | |
| 0.1 | 0.0 | 0.1 | 0.0 | 0.2 | 0.3 | 0.2 | 0.4 | 0.8 | 0.0 | |
| -0.1 | – | -0.1 | 0.0 | -0.2 | -0.3 | -0.2 | -0.4 | -0.8 | 0.0 | |
| – | 0.0 | 0.0 | 0.0 | 385 | 200 | 71 | – | – | – | |
| 38 | – | 38 | 38 | -3.2 | 0.0 | – | – | – | – | |
| 128 | 0.3 | 36 | 147 | 383 | 200 | 71 | 472 | 454 | 596 | |
| 7.0 | 0.3 | 7.0 | 94 | 300 | 94 | -117 | 259 | 79 | 188 | |
| -128 | – | -29 | -53 | -84 | -106 | -188 | -215 | -377 | -407 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.